Case Studies
How Donors & Manufacturers Benefit from China’s Updated VAT Exemptions on HIV Drugs
Adding Dolutegravir Sodium to China’s VAT-exempt HIV drug list eases costs for manufacturers and improves access for patients—here’s what stakeholders need to act on.
By NomadicTax Research Team • 5-8 min read • August 14, 2026
## Background
In 2023, China extended a VAT exemption policy for domestically produced HIV antiretroviral (ARV) drugs under **公告2023年第62号** to support epidemic control efforts. On **June 24, 2026**, through **公告2026年第18号**, **多替拉韦钠** (Dolutegravir Sodium) was added to the list of VAT-exempt ARVs, effective immediately until **December 31, 2027**. ([fgk.chinatax.gov.cn](https://fgk.chinatax.gov.cn/zcfgk/c102416/c5250687/content.html?utm_source=openai))
## Who Benefits
- **Manufacturers** producing Dolutegravir Sodium no longer need to collect VAT on sales (production and distribution stages)
- **Certified procurement agencies** under provincial HIV control programs
- **Patients** who receive these medicines free of charge through public health channels
## Requirements and Compliance for Stakeholders
- Drugs must be produced domestically and included in government procurement lists related to HIV treatment agencies. ([fgk.chinatax.gov.cn](https://fgk.chinatax.gov.cn/zcfgk/c102416/c5250687/content.html?utm_source=openai))
- Manufacturers and distributors should **separate accounting** for exempt vs non-exempt ARV products. Failure to do so could jeopardize the exemption. ([guangdong.chinatax.gov.cn](https://guangdong.chinatax.gov.cn/gdsw/zjfg/2026-07/02/content_f1ab94a2ba914d71805d971f4525a214.shtml?utm_source=openai))
## Practical Impacts
- **Cost savings**: VAT rate (normally 13%-9% for drugs) is fully exempt for Dolutegravir Sodium—lowers distribution and production cost burdens.
- **Patient access**: Lower logistical or supply chain tax burdens could improve availability and reduce health system costs.
- **Public health outcomes**: May support broader HIV treatment coverage, given improved affordability.
## Example Case
> Manufacturer X produces several HIV-ARV drugs including Dolutegravir Sodium. Under the updated policy, its production cost for this specific product is VAT free. Distributor Y procures it under government procurement and distributes to clinics—none of these stages incur VAT, provided accounting separation is maintained.
## Takeaway Points
- Check whether new ARV products are in your invoicing and benefit from the exemption.
- Ensure qualification under government procurement and free provision programs to qualify.
- Keep detailed records: product registration, supply contracts, and separate ledgers for exempt items are essential.
---
*NomadicTax Research Team authored on 2026-08-14*